Aurobindo Pharma informs about merger

01 Apr 2023 Evaluate

With reference to its letter dated August 12, 2021 informing about the approval of the Scheme of Amalgamation by the Board of Director of the Company, providing for the amalgamation of wholly owned subsidiaries of the Company, Auronext Pharma and Mviyes Pharma Ventures with the Company subject to the requisite statutory I regulatory approvals including the approval of the National Company Law Tribunal (Hyderabad Bench). Aurobindo Pharma has informed that since there were other restructuring proposals in discussion, this amalgamation was put on hold and now, the Board of Directors of the Company at its meeting held on April 1, 2023 has decided to proceed with the aforesaid Scheme of Amalgamation. The company has enclosed the details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular NO.CIR/CFD/CMD/4/2015 dated September 9, 2015 in Annexure A to this letter.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1172.30 -7.95 (-0.67%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×